Prosthesis (i.e. – artificial body members) – parts thereof – or ai – Arterial prosthesis – Stent structure
Patent
1992-12-11
1994-08-09
Pal, Asok
Prosthesis (i.e., artificial body members), parts thereof, or ai
Arterial prosthesis
Stent structure
427470, 427 225, 424422, 424423, 530815, 530816, A61F 200, A61M 2300
Patent
active
053365186
ABSTRACT:
A treatment for metallic surfaces and devices having metallic surfaces is described. A film of heptafluorobutylmethacrylate (HFBMA) is applied to a surface by radiofrequency (RF) plasma deposition and subsequently treated with a biologically active agent. A water vapor RF plasma treatment of the HFBMA coating provides reactive groups thereon which can covalently bond to the biologically active agent. Alternatively, a spacer group can be bonded to the activated HFBMA and the biologically active agent can then be bonded to the spacer group. Devices coated according to the invention possess enhanced biocompatibility and the HFBMA coatings are durable even under severe crimping and expansion conditions.
REFERENCES:
patent: 3549409 (1970-12-01), Dyck
patent: 3639141 (1972-02-01), Dyck
patent: 3826678 (1974-07-01), Hoffman et al.
patent: 4378435 (1983-03-01), Takagi et al.
patent: 4521564 (1985-06-01), Solomon
patent: 4634762 (1987-01-01), Feijen et al.
patent: 5034265 (1991-06-01), Hoffmann et al.
patent: 5100689 (1992-03-01), Goldberg et al.
C. Reilly et al., Heparin Prevents Vascular Smooth Muscle Cell Progression Through The G.sub.1 Phase Of The Cell Cycle, The Journal of Biological Chemistry, vol. 264, No. 12 (Apr. 25, 1989) pp. 6990-6995.
E. Edelman et al., Effect Controlled Advestitial Heparin Delivery On Smooth Muscle Cell Proliferation Following Endothelian Injury Proc. Natl. Acad, Sci, USA, vol. 87 (May, 1990), pp. 3773-3776.
A. Clowes et al., Kinetics of Cellular Proliferation After Arterial Injury, II. Inhibition of Smooth Muscle Growth by Heparin Laboratory Investigation, vol. 52, No. 6 (1985), pp. 611-616.
R. Majack & P. Bornstein, Regulation of Collagen Biosynthesis, Part III Collagen Biosynthesis, pp. 172-179 (1985).
H. Hartmut et al., Inhibition of Cellular Proliferation After Experimental Balloon Angioplasty by Low-Molecular-Weight Heparin, Circulation, vol. 85, No. 4, Apr. 1992, pp. 1548-1556.
H. Wessel et al., Heparin Carboxyl-Reduced Sulfated Heparin and Trestatin A. Sulfate, Anti-proliferative and anti-coagulative activities Carbohydrate Research, 204, (1990) pp. 131-139.
P. D'Amore et al., Heparin-Endothelial Cell Interactions Haemostasis 1990; 20 (Suppl. 1): 159-165.
L. Striker et al., Biology of Disease, Mesangial Cell Turnover: Effect of Heparin and Peptide Growth Factors, Laboratory Investigation vol. 64 No. 4, pp. 446-456, 1991.
Nagasaki et al., Heparin Potentiates the Action of Plasma Membrane-Associated Growth Stimulatory Activity Journal of Cellular Physiology, 133: 365-371 (1987).
Currier et al., Low Molecular Weight Heparin (Enoxaprin) Reduces Restenosis After Iliac Angioplasty in the Hypercholesterolemic Rabbit JACC vol. 17 No. 6, May 1991: 118B-25B.
J. Ip et al., The Role of Platelets, Thrombin in Hyperplasia and Restenosis After Coronary Angioplasty JACC vol. 17, No. 6, May 1991: 77B-88B.
Berk et al., Pharmacologic Roles of Heparin and Glucocorticoids to Prevent Restenosis After Coronary Angioplasty JACC vol. 17, No. 6, May, 1991: 111B-7.
Betz, Cell Culture Systems to Study Progression Inhibition of Intimal Proliferations Basic Res. Cardiol. 86: 79-86 (1991).
Narayanan Pallassana V.
Rowland Stephen M.
Stanley Kimberly D.
Achutamurthy P.
Cordis Corporation
Pal Asok
LandOfFree
Treatment of metallic surfaces using radiofrequency plasma depos does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of metallic surfaces using radiofrequency plasma depos, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of metallic surfaces using radiofrequency plasma depos will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-214997